These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism. Bergrem A; Dahm AE; Jacobsen AF; Mowinckel MC; Sandvik L; Sandset PM Br J Haematol; 2011 Jul; 154(2):241-7. PubMed ID: 21564075 [TBL] [Abstract][Full Text] [Related]
3. High plasma levels of factor VIII: an important risk factor for isolated pulmonary embolism. Erkekol FO; Ulu A; Numanoglu N; Akar N Respirology; 2006 Jan; 11(1):70-4. PubMed ID: 16423204 [TBL] [Abstract][Full Text] [Related]
4. D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study. Andreescu AC; Cushman M; Rosendaal FR Thromb Haemost; 2002 Jan; 87(1):47-51. PubMed ID: 11858188 [TBL] [Abstract][Full Text] [Related]
5. Detection of decreased response to activated protein C during pregnancy by an endogenous thrombin potential-based assay. Sugimura M; Kobayashi T; Kanayama N; Terao T Semin Thromb Hemost; 1999; 25(5):497-502. PubMed ID: 10625209 [TBL] [Abstract][Full Text] [Related]
6. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778 [TBL] [Abstract][Full Text] [Related]
7. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. De Stefano V; Martinelli I; Rossi E; Battaglioli T; Za T; Mannuccio Mannucci P; Leone G Br J Haematol; 2006 Nov; 135(3):386-91. PubMed ID: 16984390 [TBL] [Abstract][Full Text] [Related]
8. The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism. Grifoni E; Marcucci R; Ciuti G; Cenci C; Poli D; Mannini L; Liotta AA; Miniati M; Abbate R; Prisco D Semin Thromb Hemost; 2012 Mar; 38(2):230-4. PubMed ID: 22422337 [TBL] [Abstract][Full Text] [Related]
9. Resistance to activated protein C in women using oral contraceptives. Spannagl M; Dick A; Assmann A; Heinemann L; Schramm W Semin Thromb Hemost; 1998; 24(5):423-30. PubMed ID: 9834008 [TBL] [Abstract][Full Text] [Related]
10. High levels of coagulation factor XI as a risk factor for venous thrombosis. Meijers JC; Tekelenburg WL; Bouma BN; Bertina RM; Rosendaal FR N Engl J Med; 2000 Mar; 342(10):696-701. PubMed ID: 10706899 [TBL] [Abstract][Full Text] [Related]
11. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives. Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614 [TBL] [Abstract][Full Text] [Related]
12. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310 [TBL] [Abstract][Full Text] [Related]
13. Venous thrombosis, oral contraceptives and high factor VIII levels. Bloemenkamp KW; Helmerhorst FM; Rosendaal FR; Vandenbroucke JP Thromb Haemost; 1999 Sep; 82(3):1024-7. PubMed ID: 10494758 [TBL] [Abstract][Full Text] [Related]
14. Elevated fibrinogen levels are associated with risk of pulmonary embolism, but not with deep venous thrombosis. Klovaite J; Nordestgaard BG; Tybjærg-Hansen A; Benn M Am J Respir Crit Care Med; 2013 Feb; 187(3):286-93. PubMed ID: 23220916 [TBL] [Abstract][Full Text] [Related]
15. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of the factor V Leiden paradox. van Stralen KJ; Doggen CJ; Bezemer ID; Pomp ER; Lisman T; Rosendaal FR Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1872-7. PubMed ID: 18617648 [TBL] [Abstract][Full Text] [Related]
17. Sensitivity to activated protein C in patients with deep vein thrombosis during early puerperium period. Ohashi R; Sugimura M; Kawamura T; Tamura N; Kanayama N Acta Obstet Gynecol Scand; 2005 Aug; 84(8):799-801. PubMed ID: 16026408 [TBL] [Abstract][Full Text] [Related]
18. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312 [TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]